| Mrs Melissa Esteva, RPH | |
|
Miramelinda 792, Hacienda Florida, Yauco, PR 00698 | |
| (787) 267-7577 | |
| (787) 267-6630 |
| Full Name | Mrs Melissa Esteva |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Miramelinda 792, Yauco, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497181135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4752 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melissa Esteva, RPH Miramelinda 792, Hacienda Florida, Yauco, PR 00698 Ph: (787) 267-7577 | Mrs Melissa Esteva, RPH Miramelinda 792, Hacienda Florida, Yauco, PR 00698 Ph: (787) 267-7577 |
News Archive
In the online version of the New England Journal of Medicine, physicians and scientists in Heidelberg, Montreal, and Paris reported on the successful treatment of three young children who were suffering from a severe hemolytic-uremic syndrome after an infection with enterohemorrhagic Escherichia coli.
Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
From risks of violence and abuse to disrupting their development, humanitarian crises present major threats to the wellbeing of children, and for more than two decades Child Friendly Spaces have been considered one of the best ways to respond.
ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator.
› Verified 2 days ago
Jessica Correa Santiago, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Bo. Barinas, Carr 335 Km 1.6, Yauco, PR 00698 Phone: 787-675-8877 | |
Jessibel Avila, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 643 Yauco Plaza Ii, Yauco, PR 00698 Phone: 787-267-5727 | |
Mrs. Brunilda Giuliani, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 Calle Comercio, Yauco, PR 00698 Phone: 787-856-0233 Fax: 787-856-8151 | |
Daymi Loreny Muniz, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 643 Yauco Plaza Ii, Yauco, PR 00698 Phone: 787-267-5727 | |
Mr. Rafael Vargas, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 543 Calle Madrid, Yauco, PR 00698 Phone: 787-951-6103 | |
Linnette Toledo Vega, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Calle 65 Infanteria A-1, Yauco, PR 00698 Phone: 787-267-5840 Fax: 787-267-3045 | |
Mr. Alberto J Torres I, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Bo. Diego Hernandez Carr. 128 Km 3.3, Yauco, PR 00698 Phone: 787-360-6302 |